Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Accu-Break Pharmaceuticals
AddedFeb 15, 2024
UpdatedJun 18, 2026
Accu-Break Pharmaceuticals

Accu-Break Pharmaceuticals

ACCU-BREAK Pharmaceuticals develops bio-equivalent products and licenses tablet technologies for precise dosing.

HQ
Hollywood, FL, US
Founded
2001
Overview
Compare
Fundraising
Employees
Website

ACCU-BREAK Pharmaceuticals develops and licenses innovative tablet technologies for precise dosing in pharmaceuticals. Their flagship ACCU-BREAK™ technology allows tablets to be divided by hand into accurate smaller doses, enabling patients to adjust their medication intake. This technology is applicable to single drug products, combination drugs, standard and controlled release formulations, and incompatible drugs in both human and veterinary medicine.

The company's focus on dose flexibility has set a new standard in the pharmaceutical industry. ACCU-BREAK's technologies have wide-ranging applications, from improving patient compliance to potentially reducing medication costs. Their innovative approach to tablet design has positioned them as a significant player in the advancement of personalized medicine and patient-centric drug delivery systems.

Accu-Break Pharmaceuticals - Similar Companies

Accuitis logo

Accuitis

accuitis.com

Wilmington Pharmaceuticals logo

Wilmington Pharmaceuticals

Aprecia Pharmaceuticals logo

Aprecia Pharmaceuticals

aprecia.com

Pinpoint Pharma logo

Pinpoint Pharma

pinpointpharma.co

Elite Pharmaceuticals logo

Elite Pharmaceuticals

elitepharma.com

Accera logo

Accera

Concours Pharmaceuticals logo

Concours Pharmaceuticals

Patients' & Consumers' Pharma logo

Patients' & Consumers' Pharma

Auxilius Pharma logo

Auxilius Pharma

auxiliuspharma.com

Aquestive Therapeutics logo

Aquestive Therapeutics

aquestive.com

Housey Pharmaceutical Research Laboratories logo

Housey Pharmaceutical Research Laboratories

housey.com

Plumb Pharmaceuticals logo

Plumb Pharmaceuticals

plumbpharma.com

Actinobac Biomed logo

Actinobac Biomed

ScriptAssist Pharmacy logo

ScriptAssist Pharmacy

scriptassistrx.com

NovaDel Pharma logo

NovaDel Pharma

Accu-Break Pharmaceuticals - Quick Facts

Who are Accu-Break Pharmaceuticals' competitors?

Companies similar to Accu-Break Pharmaceuticals include Accuitis, Wilmington Pharmaceuticals, Aprecia Pharmaceuticals and Pinpoint Pharma.

When was Accu-Break Pharmaceuticals founded?

Accu-Break Pharmaceuticals was founded in 2001.

Where is Accu-Break Pharmaceuticals' headquarters located?

Accu-Break Pharmaceuticals' headquarters is located in Hollywood, FL, US.

When was Accu-Break Pharmaceuticals' last funding round?

Accu-Break Pharmaceuticals' most recent funding round was for $1M (USD) in May 2013.

How much has Accu-Break Pharmaceuticals raised to-date?

As of May 21, 2013, Accu-Break Pharmaceuticals has raised a total of $6.7M (USD).

How many employees does Accu-Break Pharmaceuticals have?

Accu-Break Pharmaceuticals has 7 employees as of Feb 5, 2024.

Accu-Break Pharmaceuticals - Classification

Ownership
  • Private
Geographic Exposure
  • Global
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
  • Tablet Technologies
Tags
  • Biotech
  • Healthcare
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified